Exercise May Be Protective Against Epithelial Ovarian Cancer

Share this content:
Exercise May Be Protective Against Epithelial Ovarian Cancer
Exercise May Be Protective Against Epithelial Ovarian Cancer

TUESDAY, June 21, 2016 (HealthDay News) -- Lack of exercise is associated with an increased risk of epithelial ovarian cancer (EOC) and mortality, two new studies suggest.

In one study, researchers analyzed data from 8,309 EOC patients and 12,612 women without ovarian cancer. Those who said they had done no recreational physical activity during their lives were 34 percent more likely to develop EOC than those who exercised regularly. The link between inactivity and a higher risk of EOC was seen in both normal-weight women and those who were overweight or obese. The findings were published online May 6 in Cancer Epidemiology, Biomarkers & Prevention.

The other study of 6,806 EOC patients found that women who were inactive in the years before the diagnosis were 22 to 34 percent more likely to die of the disease than those who reported a history of at least some regular weekly exercise. Again, this was true in both normal-weight women and those who were overweight or obese. The study was published online June 14 in the British Journal of Cancer.

"Our findings suggest that any amount of regular, weekly recreational physical activity may reduce the risk for and improve survival from ovarian cancer, while a lack of regular exercise throughout adulthood is associated with an increased risk of developing and dying from ovarian cancer," Kirsten Moysich, Ph.D., of the Roswell Park Cancer Institute in Buffalo, N.Y., and senior author of both studies, said in an institute news release.

Abstract 1
Full Text (subscription or payment may be required)
Abstract 2
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »